DEVY LAETITIA has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NOVIMMUNE SA, LPATH INC and MODIQUEST B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Devy Laetitia | 11 |
#2 | Ladner Robert C | 4 |
#3 | Hoet Rene | 3 |
#4 | Dransfield Daniel T | 3 |
#5 | Wood Clive R | 3 |
#6 | Henderikx Maria | 2 |
#7 | Pieters Henk | 2 |
#8 | Wood Clive | 1 |
#9 | Buckler David | 1 |
#10 | Frans Nicholas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011028883A2 | Metalloproteinase 9 and metalloproteinase 2 binding proteins | |
WO2010045388A2 | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis |